DOUGLASS HARMON: Open Payments
NPI 1720191919 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 36 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $185 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 16 | $408 |
| Braeburn Inc. | 17 | $156 |
| Gilead Sciences, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Orexo US, Inc. | 1 | $17 |
Products named: SUBLOCADE, BRIXADI, Epclusa, PAXLOVID.
Industry payments across PA — which companies pay providers there.
